Corient Capital Partners’s IQVIA IQV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.7M Buy
12,432
+15
+0.1% +$3.29K 0.2% 104
2022
Q2
$2.69M Buy
12,417
+1,582
+15% +$344K 0.2% 110
2022
Q1
$2.5M Sell
10,835
-188
-2% -$44.5K 0.17% 129
2021
Q4
$3.11M Buy
11,023
+9
+0.1% +$2.34K 0.21% 109
2021
Q3
$2.64M Sell
11,014
-120
-1% -$30.3K 0.19% 115
2021
Q2
$2.7M Sell
11,134
-37
-0.3% -$8.54K 0.2% 106
2021
Q1
$2.16M Sell
11,171
-341
-3% -$64K 0.18% 113
2020
Q4
$2.06M Buy
11,512
+1,135
+11% +$191K 0.21% 108
2020
Q3
$1.64M Buy
10,377
+2,221
+27% +$348K 0.19% 115
2020
Q2
$1.16M Buy
+8,156
New +$1.11M 0.14% 137
2020
Q1
Sell
-1,568
Closed -$242K 454
2019
Q4
$242K Sell
1,568
-168
-10% -$24.5K 0.03% 401
2019
Q3
$259K Buy
1,736
+342
+25% +$53.2K 0.04% 367
2019
Q2
$224K Buy
+1,394
New +$196K 0.03% 351

Other funds holding IQV

Corient Capital Partners's IQV Position: Q3 2022 in Review

Corient Capital Partners increased its IQVIA (IQV) stake by 0.12% in Q3 2022, buying an estimated $3.29K and bringing the position to 12,432 shares worth $2.7M. The position accounts for 0.2% of the portfolio, ranked #104.

Corient Capital Partners first reported a position in IQV in Q2 2019 and has held it in 13 quarters since. The position peaked at $3.11M in Q4 2021. 887 funds tracked by Wall St. Rank hold IQV as of Q3 2022.

  • Corient Capital Partners held 12,432 shares of IQVIA worth $2.7M as of Q3 2022.
  • Corient Capital Partners bought 15 IQVIA shares in Q3 2022, an estimated $3.29K.
  • IQVIA made up 0.2% of Corient Capital Partners's portfolio in Q3 2022, its #104 holding.
  • Corient Capital Partners first reported a position in IQVIA in Q2 2019 and has held it in 13 quarters since.
  • Corient Capital Partners's IQVIA position peaked at $3.11M in Q4 2021.
  • 887 funds tracked by Wall St. Rank held IQVIA as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.